Transvaginal Radiofrequency Ablation with Morpheus^® for Treatment of Overactive Bladder: A Pilot Study

To assess the effectiveness of transvaginal radiofrequency (RF) ablation by the  Morpheus^®at varying depths of penetration for improving urge predominate urinary incontinence symptoms in women with overactive bladder (OAB) who have contraindications to alternative first-line treatments, refractory OAB, and urge predominate mixed urinary incontinence (U-MUI) at 3 and 6 months.

Please use this link for further information:
clinicaltrials.gov